The Jawaharlal Institute of Postgraduate Medical Education & Research is a medical school located at Pondicherry, the capital of the Union Territory of Puducherry, in India. JIPMER is an Institute of National Importance and a tertiary care referral hospital.

During the past decade, Jawaharlal Institute of Postgraduate Medical Education and Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jawaharlal Institute of Postgraduate Medical Education and Research" #1 sponsor was "Jawaharlal Institute of Postgraduate Medical Education & Research" with 4 trials, followed by "Bayer" with 3 trials sponsored, "All India Institute of Medical Sciences, New Delhi" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Johnson & Johnson Private Limited" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jawaharlal Institute of Postgraduate Medical Education and Research" #1 collaborator was "Jawaharlal Institute of Postgraduate Medical Education & Research" with 3 trials as a collaborator, "Hamilton Health Sciences Corporation" with 2 trials as a collaborator, "Postgraduate Institute of Medical Education and Research" with 2 trials as a collaborator, "Mylan India Limited" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Jawaharlal Institute of Postgraduate Medical Education and Research" are "Multiple Myeloma" (2 trials), "Atrial Fibrillation" (1 trials), "Bed Sore" (1 trials), "Cochlear Hearing Loss" (1 trials) and "Critically Ill Children" (1 trials). Many other conditions were trialed in "Jawaharlal Institute of Postgraduate Medical Education and Research" in a lesser frequency.

Most popular intervention types in "Jawaharlal Institute of Postgraduate Medical Education and Research" are "Drug" (12 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (2 trials), "Darolutamide (Nubeqa, BAY1841788)" (2 trials), "Dexamethasone" (2 trials), "Placebo" (2 trials) and "Teclistamab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Jawaharlal Institute of Postgraduate Medical Education and Research" are 16 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Jawaharlal Institute of Postgraduate Medical Education and Research". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Jawaharlal Institute of Postgraduate Medical Education and Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jawaharlal Institute of Postgraduate Medical Education and Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".

Jawaharlal Institute of Postgraduate Medical Education and Research has several departments that took part in Clinical trials: "Department of Clinical Immunology , Jawaharlal Institute of Post graduate Medical Educationa and Research" - 2 trials